×
Back to Agenda
Session 4, Track A: Accelerate Precision Medicine with Model-Informed Drug Development: From Insight to Regulatory Impact
Session Chair(s)
Amy Chan
Associate Director, Regulatory Affairs, Takeda Canada Inc., Canada
Angelina Habimana
Sr. Dir. Regulatory Affairs, Teva Canada Innovation, Canada
Session 4, Track A: Accelerate Precision Medicine with Model-Informed Drug Development: From Insight to Regulatory Impact
Speaker(s)
Representative Invited
Sr Director Regulatory , TEVA PHARMACEUTICALS, Israel
Model-Informed Drug Development in Practice: Enabling Faster Development and Regulatory Decision-Making
Have an account?